Scandinavia-based VF Venture and Borean Innovation have provided early-stage medtech firm CathVision a "multimillion venture investment," the company said. The Danish company intends to use the financing to develop and market its low-noise electrophysiology recording system for treating patients with cardiac arrhythmia.
CathVision gets boost from VF Venture, Borean Innovation
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.